General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Tenaya Pharmaceuticals(NONE) RESEARCH/RESEARCH GRANTS: National Institute of Health(MODEST) OTHER FINANCIAL BENEFIT: TELERAY(NONE)

View Full Disclosure